Prestige Consumer Healthcare Inc. (NYSE:PBH) EVP Adel Mekhail Sells 9,063 Shares

Prestige Consumer Healthcare Inc. (NYSE:PBH) EVP Adel Mekhail sold 9,063 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $82.00, for a total value of $743,166.00. Following the completion of the transaction, the executive vice president now directly owns 18,365 shares in the company, valued at $1,505,930. The trade was a 33.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Prestige Consumer Healthcare Stock Performance

PBH stock opened at $82.36 on Friday. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10. The company has a 50 day moving average price of $73.29 and a 200 day moving average price of $70.25. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $83.83. The stock has a market capitalization of $4.07 billion, a PE ratio of 20.04, a price-to-earnings-growth ratio of 2.32 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, November 7th. The company reported $1.09 EPS for the quarter, meeting the consensus estimate of $1.09. The company had revenue of $283.79 million during the quarter, compared to analysts’ expectations of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The business’s revenue for the quarter was down .9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.07 EPS. Analysts forecast that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. DA Davidson reissued a “buy” rating and issued a $95.00 target price on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. Jefferies Financial Group restated a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. One analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Prestige Consumer Healthcare has an average rating of “Moderate Buy” and a consensus target price of $83.67.

Institutional Trading of Prestige Consumer Healthcare

A number of large investors have recently made changes to their positions in the company. Ariel Investments LLC boosted its stake in Prestige Consumer Healthcare by 10.7% in the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock worth $195,204,000 after purchasing an additional 274,212 shares during the period. Victory Capital Management Inc. boosted its stake in Prestige Consumer Healthcare by 9.0% in the 2nd quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock worth $142,827,000 after purchasing an additional 171,357 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in Prestige Consumer Healthcare by 19.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,575,170 shares of the company’s stock worth $113,570,000 after purchasing an additional 255,045 shares during the period. Geode Capital Management LLC boosted its stake in Prestige Consumer Healthcare by 4.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock worth $95,678,000 after purchasing an additional 50,961 shares during the period. Finally, Congress Asset Management Co. boosted its stake in Prestige Consumer Healthcare by 7.8% in the 3rd quarter. Congress Asset Management Co. now owns 865,123 shares of the company’s stock worth $62,375,000 after purchasing an additional 62,411 shares during the period. Institutional investors own 99.95% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.